Perbak Capital Partners’s GE HealthCare GEHC Stock Holding History

Perbak Capital Partners’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,941	Closed	-$423K	–	107
2026 Q1	$423K	Buy	+5,941	New	+$468K	0.1%	215

Other funds holding GEHC

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Perbak Capital Partners's GEHC Position: Q2 2026 in Review

Perbak Capital Partners sold out of GE HealthCare (GEHC) in Q2 2026, closing a stake of 5,941 shares — an estimated $423K sold.

Perbak Capital Partners first reported a position in GEHC in Q1 2026 and held it in 1 quarter. The position peaked at $423K in Q1 2026. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

Perbak Capital Partners reported no remaining GE HealthCare position as of Q2 2026 after selling out during the quarter.
Perbak Capital Partners sold 5,941 GE HealthCare shares in Q2 2026, an estimated $423K.
Perbak Capital Partners first reported a position in GE HealthCare in Q1 2026 and held it in 1 quarter.
Perbak Capital Partners's GE HealthCare position peaked at $423K in Q1 2026.
1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Perbak Capital Partners's 13F filing for Q2 2026.